216 related articles for article (PubMed ID: 25347734)
1. The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress.
Deutzmann A; Ganz M; Schönenberger F; Vervoorts J; Kappes F; Ferrando-May E
Oncogene; 2015 Aug; 34(32):4270-7. PubMed ID: 25347734
[TBL] [Abstract][Full Text] [Related]
2. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
[TBL] [Abstract][Full Text] [Related]
3. The distribution of the DEK protein in mammalian chromatin.
Hu HG; Scholten I; Gruss C; Knippers R
Biochem Biophys Res Commun; 2007 Jul; 358(4):1008-14. PubMed ID: 17524367
[TBL] [Abstract][Full Text] [Related]
4. DEK over-expression promotes mitotic defects and micronucleus formation.
Matrka MC; Hennigan RF; Kappes F; DeLay ML; Lambert PF; Aronow BJ; Wells SI
Cell Cycle; 2015; 14(24):3939-53. PubMed ID: 25945971
[TBL] [Abstract][Full Text] [Related]
5. The DEK protein--an abundant and ubiquitous constituent of mammalian chromatin.
Waldmann T; Scholten I; Kappes F; Hu HG; Knippers R
Gene; 2004 Dec; 343(1):1-9. PubMed ID: 15563827
[TBL] [Abstract][Full Text] [Related]
6. The Complexity of DEK Signaling in Cancer Progression.
Teng Y; Lang L; Jauregui CE
Curr Cancer Drug Targets; 2018; 18(3):256-265. PubMed ID: 28530531
[TBL] [Abstract][Full Text] [Related]
7. DEK oncoprotein participates in heterochromatin replication via SUMO-dependent nuclear bodies.
Pierzynska-Mach A; Czada C; Vogel C; Gwosch E; Osswald X; Bartoschek D; Diaspro A; Kappes F; Ferrando-May E
J Cell Sci; 2023 Dec; 136(23):. PubMed ID: 37997922
[TBL] [Abstract][Full Text] [Related]
8. Loss of Smu1 function de-represses DNA replication and over-activates ATR-dependent replication checkpoint.
Ren L; Liu Y; Guo L; Wang H; Ma L; Zeng M; Shao X; Yang C; Tang Y; Wang L; Liu C; Li M
Biochem Biophys Res Commun; 2013 Jun; 436(2):192-8. PubMed ID: 23727573
[TBL] [Abstract][Full Text] [Related]
9. The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.
Sandén C; Järvstråt L; Lennartsson A; Brattås PL; Nilsson B; Gullberg U
Mol Cancer; 2014 Sep; 13():215. PubMed ID: 25216995
[TBL] [Abstract][Full Text] [Related]
10. Bacterial Growth Inhibition Screen (BGIS) identifies a loss-of-function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin.
Guo H; Prell M; Königs H; Xu N; Waldmann T; Hermans-Sachweh B; Ferrando-May E; Lüscher B; Kappes F
FEBS Lett; 2021 May; 595(10):1438-1453. PubMed ID: 33686684
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions.
Wise-Draper TM; Allen HV; Jones EE; Habash KB; Matsuo H; Wells SI
Mol Cell Biol; 2006 Oct; 26(20):7506-19. PubMed ID: 16894028
[TBL] [Abstract][Full Text] [Related]
12. The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival.
Hacker KE; Bolland DE; Tan L; Saha AK; Niknafs YS; Markovitz DM; McLean K
Neoplasia; 2018 Dec; 20(12):1209-1218. PubMed ID: 30412857
[TBL] [Abstract][Full Text] [Related]
13. Distribution of the chromatin protein DEK distinguishes active and inactive CD21/CR2 gene in pre- and mature B lymphocytes.
Hu HG; Illges H; Gruss C; Knippers R
Int Immunol; 2005 Jun; 17(6):789-96. PubMed ID: 15908448
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of apoptosis related proteins regulated by proto-oncogene protein DEK.
Kim DW; Chae JI; Kim JY; Pak JH; Koo DB; Bahk YY; Seo SB
J Cell Biochem; 2009 Apr; 106(6):1048-59. PubMed ID: 19229864
[TBL] [Abstract][Full Text] [Related]
15. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.
Kappes F; Fahrer J; Khodadoust MS; Tabbert A; Strasser C; Mor-Vaknin N; Moreno-Villanueva M; Bürkle A; Markovitz DM; Ferrando-May E
Mol Cell Biol; 2008 May; 28(10):3245-57. PubMed ID: 18332104
[TBL] [Abstract][Full Text] [Related]
16. The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner.
Alexiadis V; Waldmann T; Andersen J; Mann M; Knippers R; Gruss C
Genes Dev; 2000 Jun; 14(11):1308-12. PubMed ID: 10837023
[TBL] [Abstract][Full Text] [Related]
17. An ACF1-ISWI chromatin-remodeling complex is required for DNA replication through heterochromatin.
Collins N; Poot RA; Kukimoto I; García-Jiménez C; Dellaire G; Varga-Weisz PD
Nat Genet; 2002 Dec; 32(4):627-32. PubMed ID: 12434153
[TBL] [Abstract][Full Text] [Related]
18. The nuclear DEK interactome supports multi-functionality.
Smith EA; Krumpelbeck EF; Jegga AG; Prell M; Matrka MM; Kappes F; Greis KD; Ali AM; Meetei AR; Wells SI
Proteins; 2018 Jan; 86(1):88-97. PubMed ID: 29082557
[TBL] [Abstract][Full Text] [Related]
19. DEK oncogene is overexpressed during melanoma progression.
Riveiro-Falkenbach E; Ruano Y; García-Martín RM; Lora D; Cifdaloz M; Acquadro F; Ballestín C; Ortiz-Romero PL; Soengas MS; Rodríguez-Peralto JL
Pigment Cell Melanoma Res; 2017 Mar; 30(2):194-202. PubMed ID: 27893188
[TBL] [Abstract][Full Text] [Related]
20. Melanoma proliferation and chemoresistance controlled by the DEK oncogene.
Khodadoust MS; Verhaegen M; Kappes F; Riveiro-Falkenbach E; Cigudosa JC; Kim DS; Chinnaiyan AM; Markovitz DM; Soengas MS
Cancer Res; 2009 Aug; 69(16):6405-13. PubMed ID: 19679545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
